We have set up technology innovation joint laboratories with several universities and research institutions, including West China Hospital of Sichuan University. We integrate strengths and resources from various research institutions, universities, and hospitals in and out of China, to foster partnership between industry, academia, scientists, and clinicians. We have put together an expert consultant group headed by academicians of the Chinese Academy of Engineering and foreign academicians of the U.S. National Academy of Engineering. We maintain steady long-term collaborative relationships with principal investigators ("PI") and key opinion leaders ("KOLs") at top Chinese hospitals specializing in structural heart disease, who formed a favorable view of our product candidates and are willing to advocate for their use.

With an eye toward commercialization, we participate in the formulation of industry standards and engage in academic outreach. Specifically, in terms of formulating standards, we were the only corporation among all institutional drafters of the industry standard titled Cardiovascular Implants – Cardiac Valve Repair Devices and Delivery System. In terms of academic outreach, we participate actively in industry academic conferences and networking events hosted by various industry associations and academic societies, where we promote our business and brand recognition. Further, we collaborate in-depth with the Chinese Society for Biomaterials and the Chinese Society of Biomedical Engineering in the field of basic engineering. In the future, we plan to redouble our academic outreach efforts and build up our commercialization capabilities.